OSIR

Osiris Therapeutics, Inc. News Headlines

$12.83
*  
0.09
0.7%
Get OSIR Alerts
*Delayed - data as of Oct. 21, 2014 12:07 ET  -  Find a broker to begin trading OSIR now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    OSIR Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By
Osiris Therapeutics: Still The Best Bet In Regenerative Medicine
11/27/2012 3:49:00 PM - Seeking Alpha


The Stem Cell Sector Further Validates Itself With A Successful Q3
11/14/2012 8:13:00 AM - Seeking Alpha


An Exciting Week In Cell Therapy
11/12/2012 3:57:00 AM - Seeking Alpha


Osiris Loss Lower Than Expected - Analyst Blog
11/7/2012 11:43:01 AM - Zacks.com


NeoStem To Create Value With Billion Dollar Potential
11/7/2012 10:40:00 AM - Seeking Alpha


Nobel Prize Validates Recent Stem Cell Headlines
10/16/2012 5:13:00 AM - Seeking Alpha


Mr. Market's Stem Cell Roulette
10/5/2012 11:54:00 AM - Seeking Alpha


Osiris Regains Rights from Sanofi - Analyst Blog
10/1/2012 11:45:01 AM - Zacks.com


Neuralstem Reminds Investors Of Stem Cell Rewards And Risk
9/19/2012 7:29:00 PM - Seeking Alpha


Neutral on Osiris - Analyst Blog
9/10/2012 5:35:19 PM - Zacks.com


Stem Cell Therapy: The Black And White Therapies Of The Space
9/10/2012 3:54:00 AM - Seeking Alpha


Osiris Loss Narrower Than Expected - Analyst Blog
8/1/2012 5:16:01 PM - Zacks.com


Osiris' Prochymal Encourages - Analyst Blog
7/3/2012 4:45:57 PM - Zacks.com


Osiris Keeps Neutral Recommendation - Analyst Blog
6/22/2012 7:10:57 PM - Zacks.com


Another Nod for Osiris' Prochymal - Analyst Blog
6/18/2012 6:52:00 PM - Zacks.com


Canada Approves Osiris' Prochymal - Analyst Blog
5/21/2012 5:41:47 PM - Zacks.com


Lower than Expected Loss at Osiris - Analyst Blog
5/15/2012 10:07:10 AM - Zacks.com


Neutral on Osiris Therapeutics - Analyst Blog
4/16/2012 4:48:43 PM - Zacks.com


Earnings Beat for Osiris - Analyst Blog
3/12/2012 10:21:39 AM - Zacks.com


Behavioral Finance Lessons From Magic Formula Investors
2/26/2012 5:22:00 PM - Seeking Alpha


Osiris Provides Update on Sanofi Deal - Analyst Blog
2/10/2012 6:00:01 PM - Zacks.com


5 Risky Biotech Stocks To Avoid, 2 To Consider
1/18/2012 12:14:00 PM - Seeking Alpha


Osiris Shows No Reason To Invest In Stem Cell Ideas
1/5/2012 8:43:00 AM - Seeking Alpha


Osiris' Update on Prochymal - Analyst Blog
1/4/2012 4:30:01 PM - Zacks.com


Sirus XM: Year In Review And 2012 Outlook
12/28/2011 10:43:00 AM - Seeking Alpha